TY - JOUR
T1 - Harmonized outcome measures for use in asthma patient registries and clinical practice
AU - Gliklich, Richard E.
AU - Castro, Mario
AU - Leavy, Michelle B.
AU - Press, Valerie G.
AU - Barochia, Amisha
AU - Carroll, Christopher L.
AU - Harris, Julie
AU - Rittner, Sarah S.
AU - Freishtat, Robert
AU - Panettieri, Reynold A.
AU - Mosnaim, Giselle S.
N1 - Funding Information:
Supported under contract HHSA290201400004C from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS). Statements in the manuscript do not necessarily represent the official views of or imply endorsement by AHRQ or HHS. This work was supported by the Office of the Secretary Patient-Centered Outcomes Research Trust Fund under Interagency Agreement #16-566R-16. This research was supported in part by the Intramural Research Program of the National Institutes of Health / National Heart, Lung, and Blood Institute .
Funding Information:
Supported under contract HHSA290201400004C from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS). Statements in the manuscript do not necessarily represent the official views of or imply endorsement by AHRQ or HHS. This work was supported by the Office of the Secretary Patient-Centered Outcomes Research Trust Fund under Interagency Agreement #16-566R-16. This research was supported in part by the Intramural Research Program of the National Institutes of Health/National Heart, Lung, and Blood Institute.Disclosure of potential conflict of interest: M. Castro reports grants from the National Institutes of Health (NIH) and American Lung Association (ALA) during the conduct of the study and personal fees from AstraZeneca, Aviragen, Boehringer Ingelheim, Boston Scientific, Elsevier, Genentech, 4D Pharma, Mallinckrodt, Neutronic, Nuvaira, Teva, Theravance, and VIDA and grants from Boehringer Ingelheim, Chiesi, Genentech, Novartis, Sanofi Aventis, and Vectura, all outside the submitted work. R. A. Panettieri, Jr, receives research grant support from AstraZeneca, MedImmune, Sanofi/Regeneron, Genentech, RIFM, Theratrophix, Vertex, Bristol-Myers Squibb, Gilead, and Oncoarendi and serves as a speaker, consultant, and/or member of a scientific advisory board for AstraZeneca, Medimmune, Teva, Novartis, Boehringer Ingelheim, Sanofi/Regeneron, Genentech, and RIFM. G. S. Mosnaim receives research grant support from GlaxoSmithKline and Propeller Health, owns stock options in Electrocore, and serves as a consultant and/or member of a scientific advisory board for Electrocore, GlaxoSmithKline, Teva, Novartis, Astra Zeneca, Boehringer Ingelheim, and Propeller Health. The rest of the authors declare that they have no relevant conflicts of interest. Numerous persons participated in the workgroup discussions and coordination of this effort. We acknowledge the contributions of these subjects: Elise Berliner, Sheila Heitzig, Suchitra Iyer, Margaret Johnson, Ferhat Kassamali, Elisabeth Kato, Leanne Kaye, Lisa Lang, Danica Marinac-Dabic, Mary Nix, Collette Pitzen, Rosina Pradhananga, Deepa Rastogi, Ximena Restrepo, Rachel Roan, Ann Roy, Raj Sabharwal, Sally Schoessler, Claudia Schur, David Stempel, Paul Wallace, Deidre Washington, and Lisa Wheatley.
Publisher Copyright:
© 2019 American Academy of Allergy, Asthma & Immunology
PY - 2019/9
Y1 - 2019/9
N2 - Background: Asthma, a common chronic airway disorder, affects an estimated 25 million persons in the United States and 330 million persons worldwide. Although many asthma patient registries exist, the ability to link and compare data across registries is hindered by a lack of harmonization in the outcome measures collected by each registry. Objectives: The purpose of this project was to develop a minimum set of patient- and provider-relevant standardized outcome measures that could be collected in asthma patient registries and clinical practice. Methods: Asthma registries were identified through multiple sources and invited to join the workgroup and submit outcome measures. Additional measures were identified through literature searches and reviews of quality measures and consensus statements. Outcome measures were categorized by using the Agency for Healthcare Research and Quality's supported Outcome Measures Framework. A minimum set of broadly relevant measures was identified. Measure definitions were harmonized through in-person and virtual meetings. Results: Forty-six outcome measures, including those identified from 13 registries, were curated and harmonized into a minimum set of 21 measures in the Outcome Measures Framework categories of survival, clinical response, events of interest, patient-reported outcomes, resource utilization, and experience of care. The harmonized definitions build on existing consensus statements and are appropriate for adult and pediatric patients. Conclusions: The harmonized measures represent a minimum set of outcomes that are relevant in asthma research and clinical practice. Routine and consistent collection of these measures in registries and other systems would support creation of a national research infrastructure to efficiently address new questions and improve patient management and outcomes.
AB - Background: Asthma, a common chronic airway disorder, affects an estimated 25 million persons in the United States and 330 million persons worldwide. Although many asthma patient registries exist, the ability to link and compare data across registries is hindered by a lack of harmonization in the outcome measures collected by each registry. Objectives: The purpose of this project was to develop a minimum set of patient- and provider-relevant standardized outcome measures that could be collected in asthma patient registries and clinical practice. Methods: Asthma registries were identified through multiple sources and invited to join the workgroup and submit outcome measures. Additional measures were identified through literature searches and reviews of quality measures and consensus statements. Outcome measures were categorized by using the Agency for Healthcare Research and Quality's supported Outcome Measures Framework. A minimum set of broadly relevant measures was identified. Measure definitions were harmonized through in-person and virtual meetings. Results: Forty-six outcome measures, including those identified from 13 registries, were curated and harmonized into a minimum set of 21 measures in the Outcome Measures Framework categories of survival, clinical response, events of interest, patient-reported outcomes, resource utilization, and experience of care. The harmonized definitions build on existing consensus statements and are appropriate for adult and pediatric patients. Conclusions: The harmonized measures represent a minimum set of outcomes that are relevant in asthma research and clinical practice. Routine and consistent collection of these measures in registries and other systems would support creation of a national research infrastructure to efficiently address new questions and improve patient management and outcomes.
KW - Asthma
KW - common data element
KW - data standard
KW - harmonization
KW - outcome measure
KW - patient outcome
KW - patient registry
UR - http://www.scopus.com/inward/record.url?scp=85063673780&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2019.02.025
DO - 10.1016/j.jaci.2019.02.025
M3 - Article
C2 - 30857981
AN - SCOPUS:85063673780
SN - 0091-6749
VL - 144
SP - 671-681.e1
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3
ER -